Analgesic N-(2-heterocyclic-amino cycloaliphatic) benzamides

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Fungus – except allergen – or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

260239A, 2603264, 544400, 546205, 546234, 424244, 424250, 424267, A61K 3140, C07D20704, C07D29514, A61K 31445

Patent

active

041973089

ABSTRACT:
Cis- and trans-N-(2-aminocycloaliphatic)benzamide compounds of the formula ##STR1## e.g., N-methyl-N-[2-(N-pyrrolidinyl)cyclohexyl]-3,4- dichlorobenzamide, and their pharmaceutically acceptable salts, have been found to have potent analgesic activity, and compositions containing these compounds useful in pharmaceutical dosage unit form for alleviating pain in warm blooded animals, as well as methods for alleviating pain in animals with these compositions. Processes for preparing the compounds are also disclosed.

REFERENCES:
patent: 3510492 (1970-05-01), Szmuszkovicz
patent: 3510505 (1970-05-01), Pribyl et al.
patent: 3647804 (1972-03-01), Rynbrandt et al.
patent: 3652559 (1972-03-01), Szmuskovicz
patent: 3852347 (1974-12-01), Krapcho
patent: 3975443 (1976-08-01), Harper et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Analgesic N-(2-heterocyclic-amino cycloaliphatic) benzamides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Analgesic N-(2-heterocyclic-amino cycloaliphatic) benzamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analgesic N-(2-heterocyclic-amino cycloaliphatic) benzamides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-973736

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.